Pediatric Hematology & Oncology & BMT
Pediatric Hematology & Oncology & BMT
Pediatric Hematology pertains to the pediatric specialty that addresses disorders affecting blood production and clotting specifically in children. In their early years, children are susceptible to blood production defects stemming from factors such as nutritional deficiencies, which can lead to conditions like megaloblastic anemia, iron deficiency anemia, or hemolytic anemias including Thalassemia and Sickle Cell Anemia.
On the other hand, Pediatric Oncology represents a specialized domain of expertise dedicated to treating and curing children afflicted with conditions such as acute leukemia, neuroblastoma, lymph node cancer, and brain tumors, ultimately enhancing their quality of life. The precise cause of childhood malignancies remains largely unknown, but it is noteworthy that a significant proportion of these tumors and cancers are amenable to treatment.
Within the confines of Rainbow Children's Hospital, our Pediatric Hematology and Oncology departments possess a wealth of experience in managing high-risk cases, including Acute Leukemia, Lymphomas, and Solid Tumors. Our comprehensive care framework includes the provision of Intensive Care Services, Neurology, Nephrology, and Hepatology. This holistic approach is further fortified by an Infection Control Team, Dietician, Nutritionist, and Psychology experts, all working in unison to ensure the overall well-being of children following their treatment journey. Notably, we have successfully treated over 1400 cases of Pediatric malignancies, offering intensive care and curative solutions for children who need them most. Our team of expert Pediatric Oncologists possesses extensive experience in addressing a wide range of cancers and conducting bone marrow transplants, offering a fresh lease on life to these young patients.
The Department of Pediatric Hematology and Oncology at Rainbow Children’s Hospital is well-equipped to provide care to children diagnosed with the following conditions:
Acute leukemia (blood cancer)
Neuroblastoma
Lymphomas (lymph node cancer)
Brain tumors
Germ cell tumors
Wilms tumor (affecting the kidney)
Osteosarcoma (bone-related)
Ewing’s sarcoma
Rhabdomyosarcomas
Hepatoblastoma (related to the liver)
Soft tissue sarcomas
Refractory anemias, including remitting relapsing autoimmune hemolytic anemias
Chronic Immune Thrombocytopenia (ITP) requiring second-line medications
Hemoglobinopathies
Nutritional anemias
Other inherited anemias
Aplastic anemias demanding Immuno-Suppressive Therapy alongside CSA and ATG.